دورية أكاديمية

Antimicrobial photodynamic therapy with methylene blue and its derivatives in animal studies: Systematic review.

التفاصيل البيبلوغرافية
العنوان: Antimicrobial photodynamic therapy with methylene blue and its derivatives in animal studies: Systematic review.
المؤلفون: Cardozo APM; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil., da Silva DFT; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil., Fernandes KPS; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil., Ferreira RC; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil., Lino-Dos-Santos-Franco A; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil., Rodrigues MFSD; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil., Motta LJ; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil., Cecatto RB; Postgraduate Program in Biophotonics-Medicine Universidade Nove de Julho, Universidade Nove de Julho, São Paulo, Brazil.
المصدر: Photodermatology, photoimmunology & photomedicine [Photodermatol Photoimmunol Photomed] 2024 Jul; Vol. 40 (4), pp. e12978.
نوع المنشور: Journal Article; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 9013641 Publication Model: Print Cited Medium: Internet ISSN: 1600-0781 (Electronic) Linking ISSN: 09054383 NLM ISO Abbreviation: Photodermatol Photoimmunol Photomed Subsets: MEDLINE
أسماء مطبوعة: Publication: <2010-> : Oxford : Blackwell
Original Publication: Copenhagen : Munksgaard, c1990-
مواضيع طبية MeSH: Methylene Blue*/pharmacology , Methylene Blue*/therapeutic use , Photochemotherapy*/methods , Photosensitizing Agents*/pharmacology , Photosensitizing Agents*/therapeutic use, Animals ; Disease Models, Animal
مستخلص: Background: Infections are complications in the wound healing process, and their treatment can lead to antibiotic overuse and bacterial resistance. Antimicrobial photodynamic therapy (aPDT) is used to treat infectious diseases caused by fungi, viruses, or bacteria. Methylene blue (MB) and its derivatives are commonly used dyes in antimicrobial photodynamic therapy (aPDT-MB).
Methods: This study is a PRISMA systematic review of animal models used to discuss the usefulness and therapeutic parameters of aPDT-MB or its derivatives for treating infected skin wounds.
Results: After an extensive literature review, 13 controlled trials totaling 261 animals were selected to evaluate skin infection by leishmaniasis and cutaneous bacterial and fungal infections. All studies found results favoring the use of aPDT-MB. Great variability in parameters was found for radiant exposure from 12 to 360 J/cm 2 , MB diluted in saline solution or distilled water, irradiation time from 40 to 3600 s, irradiance most commonly at a maximum of 100 mW/cm 2 , and wavelength used mainly in the 630-670 nm range.
Conclusion: MB is a safe and promising agent used as a photosensitizer in aPDT for skin-infected lesions. There is great variability in the parameters found. Comparisons concerning concentration, irradiation time, and light intensity need to be performed.
(© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
References: Leaper D, Assadian O, Edmiston CE. Approach to chronic wound infections. Br J Dermatol. 2015;173(2):351‐358. doi:10.1111/bjd.13677.
Sen CK. Human wound and its burden: updated 2020 compendium of estimates. Adv Wound Care (New Rochelle). 2021;10(5):281‐292. doi:10.1089/wound.2021.0026.
Marques R, Lopes M, Ramos P, Neves‐Amado J, Alves P. Prognostic factors for delayed healing of complex wounds in adults: a scoping review. Int Wound J. 2023;20:2869‐2886. doi:10.1111/iwj.14128.
Norman G, Shi C, Westby MJ, et al. Bacteria and bioburden and healing in complex wounds: a prognostic systematic review. Wound Repair Regen. 2021;29(3):466‐477. doi:10.1111/wrr.12898.
Filius PM, Gyssens IC. Impact of increasing antimicrobial resistance on wound management. Am J Clin Dermatol. 2002;3(1):1‐7. doi:10.2165/00128071-200203010-00001.
Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic therapy – mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098‐1107. doi:10.1016/j.biopha.2018.07.049.
Cieplik F, Deng D, Crielaard W, et al. Antimicrobial photodynamic therapy – what we know and what we don't. Crit Rev Microbiol. 2018;44(5):571‐589. doi:10.1080/1040841X.2018.1467876.
Oyama J, Fernandes Herculano Ramos‐Milaré ÁC, Lopes Lera‐Nonose DSS, et al. Photodynamic therapy in wound healing in vivo: a systematic review. Photodiagn Photodyn Ther. 2020;30:101682. doi:10.1016/j.pdpdt.2020.101682.
Sun Y, Ogawa R, Xiao B, et al. Antimicrobial photodynamic therapy in skin wound healing: a systematic review of animal studies. Int Wound J. 2020;17(2):285‐299. doi:10.1111/iwj.13269.
Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci. 2004;3(5):436‐450. doi:10.1039/b311900a.
Benov L. Photodynamic therapy: current status and future directions. Med Princ Pract. 2015;24(Suppl. 1):14‐28. doi:10.1159/000362416.
Schirmer RH, Adler H, Pickhardt M, Mandelkow E. Lest we forget you — methylene blue …. Neurobiol Aging. 2011;32(12):2325.e7‐16. doi:10.1016/j.neurobiolaging.2010.12.012.
Küpfer A, Aeschlimann C, Wermuth B, Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene‐blue. Lancet. 1994;343(8900):763‐764. doi:10.1016/S0140-6736(94)91839-2.
Williamson LM, Cardigan R, Prowse C v. Methylene blue‐treated fresh‐frozen plasma: what is its contribution to blood safety? Transfusion (Paris). 2003;43(9):1322‐1329. doi:10.1046/j.1537-2995.2003.00483.x.
Wainwright M, Crossley KB. Methylene blue – a therapeutic dye for all seasons? J Chemother. 2002;14(5):431‐443. doi:10.1179/joc.2002.14.5.431.
de Oliveira AB, Ferrisse TM, Fontana CR, Basso FG, Brighenti FL. Photodynamic therapy for treating infected skin wounds: a systematic review and meta‐analysis from randomized clinical trials. Photodiagn Photodyn Ther. 2022;40:103118. doi:10.1016/j.pdpdt.2022.103118.
Bhatta AK, Keyal U, Wang XL. Photodynamic therapy for onychomycosis: a systematic review. Photodiagn Photodyn Ther. 2016;15:228‐235. doi:10.1016/j.pdpdt.2016.07.010.
Carrinho PM, Andreani DIK, Morete V d A, Iseri S, Navarro RS, Villaverde AB. A study on the macroscopic morphometry of the lesion area on diabetic ulcers in humans treated with photodynamic therapy using two methods of measurement. Photomed Laser Surg. 2018;36(1):44‐50. doi:10.1089/pho.2017.4305.
Tardivo JP, Adami F, Correa JA, Pinhal MAS, Baptista MS. A clinical trial testing the efficacy of PDT in preventing amputation in diabetic patients. Photodiagn Photodyn Ther. 2014;11(3):342‐350. doi:10.1016/j.pdpdt.2014.04.007.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta‐analysis protocols (PRISMA‐P) 2015 statement. Syst Rev. 2015;4(1):1. doi:10.1186/2046-4053-4-1.
Sena E, van der Worp HB, Howells D, Macleod M. How can we improve the pre‐clinical development of drugs for stroke? Trends Neurosci. 2007;30(9):433‐439. doi:10.1016/j.tins.2007.06.009.
Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke. 2004;35(5):1203‐1208. doi:10.1161/01.STR.0000125719.25853.20.
Zolfaghari PS, Packer S, Singer M, et al. In vivo killing of Staphylococcus aureus using a light‐activated antimicrobial agent. BMC Microbiol. 2009;9(1):27. doi:10.1186/1471-2180-9-27.
Nascimento CL, Ribeiro MS, Sellera FP, Dutra GHP, Simões A, Teixeira CR. Comparative study between photodynamic and antibiotic therapies for treatment of footpad dermatitis (bumblefoot) in Magellanic penguins (Spheniscus magellanicus). Photodiagn Photodyn Ther. 2015;12(1):36‐44. doi:10.1016/j.pdpdt.2014.12.012.
do Nascimento Volpe RAF, Navasconi TR, dos Reis VN, et al. Photodynamic therapy for the treatment of American Tegumentary Leishmaniasis: evaluation of therapies Association in Experimentally Infected Mice with Leishmania (Leishmania) amazonensis. J Lasers Med Sci. 2018;9(4):274‐282. doi:10.15171/jlms.2018.49.
Rineh A, Dolla NK, Ball AR, et al. Attaching the NorA efflux pump inhibitor INF55 to methylene blue enhances antimicrobial photodynamic inactivation of methicillin‐resistant Staphylococcus aureus in vitro and in vivo. ACS Infect Dis. 2017;3(10):756‐766. doi:10.1021/acsinfecdis.7b00095.
Peloi LS, Biondo CEG, Kimura E, et al. Photodynamic therapy for American cutaneous leishmaniasis: the efficacy of methylene blue in hamsters experimentally infected with Leishmania (Leishmania) amazonensis. Exp Parasitol. 2011;128(4):353‐356. doi:10.1016/j.exppara.2011.04.009.
Li J, Zhu M, An L, Chen F, Zhang X. Fungicidal efficacy of photodynamic therapy using methylene blue against Sporothrix globosa in vitro and in vivo. Eur J Dermatol. 2019;29(2):160‐166. doi:10.1684/ejd.2019.3527.
Krasnoselskiy NV, Simonova LI, Gertman VZ, Pushkar ES. Photodynamic therapy effect on healing of radiation skin ulcer infected with pseudomonas aeruginosa. Probl Radiac Med Radiobiol. 2017;22:202‐207.
Fila G, Kasimova K, Arenas Y, et al. Murine model imitating chronic wound infections for evaluation of antimicrobial photodynamic therapy efficacy. Front Microbiol. 2016;7:1258. doi:10.3389/fmicb.2016.01258.
El‐Khordagui L, El‐Sayed N, Galal S, El‐Gowelli H, Omar H, Mohamed M. Photosensitizer‐eluting nanofibers for enhanced photodynamic therapy of wounds: a preclinical study in immunocompromized rats. Int J Pharm. 2017;520(1–2):139‐148. doi:10.1016/j.ijpharm.2017.02.004.
Dai T, Bil de Arce VJ, Tegos GP, Hamblin MR. Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother. 2011;55(12):5710‐5717. doi:10.1128/AAC.05404-11.
Cabral FV, Sabino CP, Dimmer JA, Sauter IP, Cortez MJ, Ribeiro MS. Preclinical investigation of methylene blue‐mediated antimicrobial photodynamic therapy on Leishmania parasites using real‐time bioluminescence. Photochem Photobiol. 2020;96(3):604‐610. doi:10.1111/php.13188.
Sbeghen MR, Voltarelli EM, Campois TG, et al. Topical and intradermal efficacy of photodynamic therapy with methylene blue and light‐emitting diode in the treatment of cutaneous Leishmaniasis caused by Leishmania braziliensis. J Lasers Med Sci. 2015;6(3):106‐111. doi:10.15171/jlms.2015.03.
Ragàs X, Dai T, Tegos GP, Agut M, Nonell S, Hamblin MR. Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers Surg Med. 2010;42(5):384‐390. doi:10.1002/lsm.20922.
Dharmaratne P, Sapugahawatte DN, Wang B, et al. Contemporary approaches and future perspectives of antibacterial photodynamic therapy (aPDT) against methicillin‐resistant Staphylococcus aureus (MRSA): a systematic review. Eur J Med Chem. 2020;200:112341. doi:10.1016/j.ejmech.2020.112341.
Wainwright M, Phoenix DA, Rice L, Burrow SM, Waring J. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J Photochem Photobiol B. 1997;40(3):233‐239. doi:10.1016/S1011-1344(97)00061-4.
Wainwright M, Phoenix DA, Laycock SL, Wareing DRA, Wright PA. Photobactericidal activity of phenothiazinium dyes against methicillin‐resistant strains of Staphylococcus aureus. FEMS Microbiol Lett. 1998;160(2):177‐181. doi:10.1111/j.1574-6968.1998.tb12908.x.
Phoenix DA, Sayed Z, Hussain S, Harris F, Wainwright M. The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus. FEMS Immunol Med Microbiol. 2003;39(1):17‐22. doi:10.1016/S0928-8244(03)00173-1.
Ghorbani J, Rahban D, Aghamiri S, Teymouri A, Bahador A. Photosensitizers in antibacterial photodynamic therapy: an overview. Laser Ther. 2018;27(4):293‐302. doi:10.5978/islsm.27_18-RA-01.
Prates RA, Kato IT, Ribeiro MS, Tegos GP, Hamblin MR. Influence of multidrug efflux systems on methylene blue‐mediated photodynamic inactivation of Candida albicans. J Antimicrob Chemother. 2011;66(7):1525‐1532. doi:10.1093/jac/dkr160.
Shen X, Dong L, He X, et al. Treatment of infected wounds with methylene blue photodynamic therapy: an effective and safe treatment method. Photodiagn Photodyn Ther. 2020;32:102051. doi:10.1016/j.pdpdt.2020.102051.
Sperandio FF, Simões A, Aranha ACC, Corrêa L, Machado O, de Sousa SC. Photodynamic therapy mediated by methylene blue dye in wound healing. Photomed Laser Surg. 2010;28(5):581‐587. doi:10.1089/pho.2009.2601.
Yang Z, Hu X, Zhou L, et al. Photodynamic therapy accelerates skin wound healing through promoting re‐epithelialization. Burns Dent Traumatol. 2021;9:tkab008. doi:10.1093/burnst/tkab008.
Algorri JF, Ochoa M, Roldán‐Varona P, Rodríguez‐Cobo L, López‐Higuera JM. Photodynamic therapy: a compendium of latest reviews. Cancers (Basel). 2021;13(17):4447. doi:10.3390/cancers13174447.
Zuhayri H, Nikolaev VV, Lepekhina TB, Sandykova EA, Krivova NA, Kistenev YV. The in vivo quantitative assessment of the effectiveness of low‐dose photodynamic therapy on wound healing using optical coherence tomography. Pharmaceutics. 2022;14(2):399. doi:10.3390/pharmaceutics14020399.
de Melo Rambo CS, Silva JA, Serra AJ, et al. Comparative analysis of low‐level laser therapy (660 nm) on inflammatory biomarker expression during the skin wound‐repair process in young and aged rats. Lasers Med Sci. 2014;29(5):1723‐1733. doi:10.1007/s10103-014-1582-8.
Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37(5):1528‐1542. doi:10.1177/147323000903700531.
Arnold F, West DC. Angiogenesis in wound healing. Pharmacol Ther. 1991;52:407‐422.
Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017;34(3):599‐610. doi:10.1007/s12325-017-0478-y.
فهرسة مساهمة: Keywords: animal models; antimicrobial photodynamic chemotherapy; methylene blue; photobiomodulation; wounds
المشرفين على المادة: T42P99266K (Methylene Blue)
0 (Photosensitizing Agents)
تواريخ الأحداث: Date Created: 20240606 Date Completed: 20240607 Latest Revision: 20240606
رمز التحديث: 20240607
DOI: 10.1111/phpp.12978
PMID: 38845020
قاعدة البيانات: MEDLINE